This review explores the management of healthcare data value in dynamic contexts, suggesting new assetization strategies.
This review centers on the core role of medical data in new quality productive forces. It systematically examines the current landscape of the rapid expansion of these data and explores their value in depth. Drawing on value chain theory, the paper proposes a “value flow” analytical framework, and conducts an in‐depth exploration of the full dynamic process through which medical data are converted into data assets. We defined “value flow” as a process in which data value undergoes directional transmission, integration, amplification, and ultimate release along a chain‐like pathway spanning data collection, governance, analysis, application, and circulation. We argue that a focus solely on the static components of the “value chain” cannot fully capture the holistic landscape of the transformation. Instead, it is essential to integrate dynamic value flow to systematically resolve the core challenges inherent in this transformation. The tracking and optimization of value flow direction supports objectives including: (1) Eliminating data silos and process breakpoints, and guaranteeing the seamless flow of value across clinical practice, scientific research, administrative management and other application scenarios; (2) Defining the contributions and rights allocation of stakeholders at each stage, providing a robust basis for the development of a compliant and sustainable profit‐sharing mechanism; (3) Charting the operational orientation of data as assets, facilitating the precise allocation of data assets to high‐demand scenarios and maximizing the realization of their inherent value. This paper therefore focuses on the assetization of medical data, and incorporates value flow to suggest a sustainable value release mechanism and core components of asset management after assetization. It therefore establishes a factor‐oriented management framework for data assets rooted in value chain theory and guided by value flow direction. This framework offers medical institutions practical guidance for integrating theoretical underpinnings and operational feasibility of data assetization, supporting the management of data across its full life‐cycle, including value monetization and strategic planning of data assets.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: